Nautilus Biotechnology (NAUT) Share-based Compensation (2020 - 2026)
Nautilus Biotechnology has reported Share-based Compensation over the past 7 years, most recently at $1.4 million for Q1 2026.
- Quarterly results put Share-based Compensation at $1.4 million for Q1 2026, down 37.18% from a year ago — trailing twelve months through Mar 2026 was $6.0 million (down 48.63% YoY), and the annual figure for FY2025 was $6.8 million, down 46.11%.
- Share-based Compensation reached $1.4 million in Q1 2026 per NAUT's latest filing, down from $1.5 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $3.3 million in Q2 2024 and bottomed at $1.4 million in Q1 2026.
- Median Share-based Compensation over the past 5 years was $2.9 million (2023), compared with a mean of $2.6 million.
- The largest annual shift saw Share-based Compensation soared 57.93% in 2022 before it crashed 53.02% in 2025.
- Over 5 years, Share-based Compensation stood at $2.8 million in 2022, then grew by 8.47% to $3.1 million in 2023, then grew by 1.66% to $3.1 million in 2024, then crashed by 52.91% to $1.5 million in 2025, then dropped by 7.41% to $1.4 million in 2026.
- Business Quant data shows Share-based Compensation for NAUT at $1.4 million in Q1 2026, $1.5 million in Q4 2025, and $1.5 million in Q3 2025.